Short‐Course Therapy for Right‐Side Endocarditis Due to Staphylococcus aureus in Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
A prospective, randomized clinical trial among drug abusers was conducted to assess the efficacy and safety of a short course of a combination of a glycopeptide (vancomycin or teicoplanin) and gentamicin compared with a combination of cloxacillin and gentamicin for treatment of right-side endocarditis caused by Staphylococcus aureus. Therapeutic success was significantly more frequent with cloxacillin than with a glycopeptide. No adverse effects were noted among patients in the cloxacillin group. A 14-day course of vancomycin or teicoplanin plus gentamicin is ineffective in this instance because it is associated with a high rate of clinical and microbiological failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in IDUs with uncomplicated right-sided S aureus IE (no evidence of renal failure, extrapulmonary metastatic infections, aortic or mitral valve involvement, meningitis, or infection by MRSA), combined short-course (2 weeks) β-lactam plus aminoglycoside therapy was highly effective in several studies.91,92,148”
In the citing paper
“In contrast, short-course regimens with glycopeptides (teicoplanin or vancomycin) plus gentamicin appeared to be less effective for right-sided S aureus IE caused by either MSSA or MRSA strains.148”
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Clinical Microbiology Procedures Handbook
(2016) · ASM Press eBooks · doi:10.1128/9781555818814 · Cited by 2,240
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
Rybak, M. J., Albrecht, L. M., Boike, S. C., & Chandrasekar, P. H. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.679 · Cited by 388
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-8-619 · Cited by 214 · cited 2×
“aureus endocarditis, whereas 47 of 50 patients with methicillin-susceptible isolates were cured with a 2-week course of nafcillin-tobramycin therapy [1].”
BackgroundRibera, E., Gomez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, M. T., Almirante, B., Ocana, I., & Pahissa, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00005 · Cited by 187 · cited 1×
“Moreover, a recent study has confirmed similar results for patients who received 2 weeks of cloxacillin monotherapy, which indicates that adding an aminoglycoside may not be necessary because it does not provide any therapeutic advantage [2].”
ResultGilbert, D. N., Wood, C. A., & Kimbrough, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.79 · Cited by 110
Mild Nephrotoxicity Associated With Vancomycin Use
Downs, N. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390080053013 · Cited by 102
Greenberg, R. N. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2392 · Cited by 87
Vancomycin therapy of bacterial endocarditis
Hook, E. W., & Johnson, W. D. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90766-0 · Cited by 76
Right-sided endocarditis caused by Staphylococcus aureus in drug abusers
Fortún, J., Pérez-Molina, J. A., Añón, M. T., Martínez-Beltrán, J., Loza, E., & Guerrero, A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.525 · Cited by 65
Self-citationPharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis
Crémieux, A., & Carbon, C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2069 · Cited by 64
van der Auwera, P., Aoun, M., & Meunier, F. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.451 · Cited by 62
Vancomycin Therapy for Infective Endocarditis
GERACI, J. E., & Wilson, W. R. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement.s250 · Cited by 62
Dosage recommendations for teicoplanin
Wilson, A. P. R., Grüneberg, R. N., & Neu, H. C. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.6.792 · Cited by 58
Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis
Rybak, M. J., Lerner, S. A., Levine, D. P., Albrecht, L. M., McNeil, P., Thompson, G. A., Kenny, M. T., & Yuh, L. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.4.696 · Cited by 55
Laethem, Y. V., Hermans, P., Wit, S. D., Goosens, H., & Clumeck, N. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/21.suppl_a.81 · Cited by 41
Glycopeptides and nephrotoxicity
Chow, A. W., & Azar, R. (1994) · Intensive Care Medicine · doi:10.1007/bf01713979 · Cited by 38
Vancomycin Therapy for Infective Endocarditis
GERACI, J. E., & Wilson, W. R. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement_2.s250 · Cited by 38
Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin
Lagast, H., Dodion, P. F., & Klastersky, J. A. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.4.513 · Cited by 29
Charbonneau, P., Harding, I., Garaud, J., Aubertin, J., Brunet, F. P., & Domart, Y. (1994) · Intensive Care Medicine · doi:10.1007/bf01713981 · Cited by 28
Teicoplanin in Endocarditis: A Multicentre, Open European Study
Lewis, P. J., Martino, P., Mosconi, G., & Harding, I. (2009) · Chemotherapy · doi:10.1159/000239373 · Cited by 25
Liu, C., Lee, W., Fung, C.-P., Cheng, N.-C., Liu, C.-L., Yang, S.-P., & Chen, S.-L. (1996) · Clinical Drug Investigation · doi:10.2165/00044011-199612020-00003 · Cited by 24
Mild nephrotoxicity associated with vancomycin use
Downs, N. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.8.1777 · Cited by 15
Stanley, D., McGrath, B. J., Lamp, K. C., & Rybak, M. J. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02786.x · Cited by 10
Research works printed but not linked: 2
- Anhalt JP, 1991, DC: American Society for Microbiology, 1192
- Griffin J, 1992, DC: American Society for Microbiology, 5, 17
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
“, vancomycin and teicoplanin) than for those receiving antistaphylococcal penicillins (101, 105).”
BackgroundBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“In contrast, short-course regimens with glycopeptides (teicoplanin or vancomycin) plus gentamicin appeared to be less effective for right-sided S aureus IE caused by either MSSA or MRSA strains.(148) These glycopeptides may be less effective because of limited bactericidal activity, poor penetration into vegetations,…”
ResultGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaun, E., Pettersson, G. B., Schäfers, H. J., & Prendergast, B. D. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 715
“, 2001 (148) Is a short course of glycopeptide (vancomycin or teicoplanin) and gentamicin as effective as combination cloxacillin and gentamicin for treatment of right-sided NVE caused by methicillin-sensitive S aureus? Adult IVDUs with right-sided NVE caused by MSSA Glycopeptide therapy is inferior to cloxacillin”
Background
Metadata
- Authors
- Fortún, J., Navas, E., Martínez‐Beltrán, J., Pérez‐Molina, J., Martín‐Dávila, P., Guerrero, A., & Moreno, S.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07
- Volume
- 33
- Issue
- 1
- Pages
- 120-125
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2144592242
- Semantic Scholar
- f5a3d69c04b44df6f88c0ed011b8287037b67ff4
- Cited by
- 126
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- right-sided endocarditis, Staphylococcus aureus, drug abusers, short-course antibiotic therapy, cloxacillin, vancomycin, teicoplanin, gentamicin, glycopeptides, combination antibiotic therapy, treatment failure
- MeSH terms
- Adolescent, Adult, Anti-Bacterial Agents, Cloxacillin, Drug Therapy, Combination, Endocarditis, Bacterial, Female, Gentamicins, Glycopeptides, Humans, Male, Prospective Studies, Staphylococcal Infections, Staphylococcus aureus, Substance Abuse, Intravenous, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.